Bart van de Sluis

Professor Bart van de Sluis holds the Chair of Molecular Genetics and Translational Biology at the Faculty of Medical Sciences, University of Groningen. He leads the Transgenic Mouse Clinic for Aging Research and oversees the CRISPR facility. His primary affiliation is with the Department of Molecular Genetics, focusing on lipid metabolism, cholesterol transport, and liver disease mechanisms. He is actively involved in translational research bridging basic science and clinical applications.

Research interests include inflammation, vesicular transport pathways, and the role of mouse transgenesis in modeling human diseases. His work emphasizes aging-related disorders, atherosclerosis, and senescence biology.

Key contributions include studies on senescent cell clearance (Nature, 2011), CRISPR-based genome editing in lipid research (2016), and consensus statements on LDL-driven cardiovascular disease (Eur Heart J, 2017/2020). His recent work explores T cell cholesterol dynamics in atherosclerosis (Nat Commun, 2022).

He serves as a project leader for aging research infrastructure and contributes to both basic and clinical translational projects. No specific awards are listed, though his high-impact publications reflect significant scientific recognition.

Lab facilities include the Transgenic Mouse Clinic and CRISPR facility, supporting genetic model development for lipid and aging research.